Author： Robinson Rebecca L Jones Megan L
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.8, 2006-06, pp. : 1027-1039
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Need for Pharmacoeconomic Evaluations in the NHS
By Griffin J.P.
PharmacoEconomics, Vol. 14, Iss. 3, 1998-09 ,pp. :
Access to resources
Recommend
Budget impacts and pharmacoeconomic evaluations
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 250, 2000-01 ,pp. :
Accounting for Noncompliance in Pharmacoeconomic Evaluations
By Hughes D.A. Bagust A. Haycox A. Walley T.
PharmacoEconomics, Vol. 19, Iss. 12, 2001-01 ,pp. :
Reporting Pharmacoeconomic Evaluations
By Carswell C.I. Paladino J.A.
PharmacoEconomics, Vol. 23, Iss. 11, 2005-01 ,pp. :
The Role of Pharmacoeconomic Evaluations in Disease Management
PharmacoEconomics, Vol. 14, Iss. 1, 1998-07 ,pp. :